I. Koornneef

461 total citations
11 papers, 396 citations indexed

About

I. Koornneef is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, I. Koornneef has authored 11 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in I. Koornneef's work include TGF-β signaling in diseases (3 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). I. Koornneef is often cited by papers focused on TGF-β signaling in diseases (3 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). I. Koornneef collaborates with scholars based in Netherlands. I. Koornneef's co-authors include A.J.M. van den Eijnden-van Raaij, Siegfried W. de Laat, E.J.J. van Zoelen, W. Kruijer, I M Kramer, Christine L. Mummery, W J van Venrooij, Rolf P. de Groot, A. Feijen and M C Slootweg and has published in prestigious journals such as Journal of Clinical Investigation, The EMBO Journal and Analytical Biochemistry.

In The Last Decade

I. Koornneef

11 papers receiving 386 citations

Peers

Countries citing papers authored by I. Koornneef

Since Specialization

Citations

This map shows the geographic impact of I. Koornneef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Koornneef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Koornneef more than expected).

Fields of papers citing papers by I. Koornneef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Koornneef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Koornneef. The network helps show where I. Koornneef may publish in the future.

Co-authorship network of co-authors of I. Koornneef

This figure shows the co-authorship network connecting the top 25 collaborators of I. Koornneef. A scholar is included among the top collaborators of I. Koornneef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Koornneef. I. Koornneef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Epitope regions on U1 small nuclear RNA recognized by anti-U1RNA-specific autoantibodies. 1992 ·Journal of Clinical Investigation ·Rene Hoet, (unknown), (unknown), I. Koornneef, W J van Venrooij	20
2	Changes in anti–U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome 1992 ·Arthritis & Rheumatism ·(unknown), I. Koornneef, W J van Venrooij, D. J. De Rooij, L B van de Putte	48
3	Phosphorylation of nuclear protein is an early event in TGFβ1 action 1991 ·Biochemical and Biophysical Research Communications ·IJsbrand M. Kramer, I. Koornneef, Carlie de Vries, Rolf P. de Groot, Siegfried W. de Laat, A.J.M. van den Eijnden-van Raaij, W. Kruijer	16
4	Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression 1991 ·Journal of Molecular Endocrinology ·M C Slootweg, Rolf P. de Groot, M. P. M. Herrmann‐Erlee, I. Koornneef, W. Kruijer, (unknown)	64
5	TGF-beta 1 induces phosphorylation of the cyclic AMP responsive element binding protein in ML-CCl64 cells. 1991 ·The EMBO Journal ·I M Kramer, I. Koornneef, Siegfried W. de Laat, (unknown)	75
6	Characterization of polyclonal anti-peptide antibodies specific for transforming growth factor β2 1990 ·Journal of Immunological Methods ·A.J.M. van den Eijnden-van Raaij, I. Koornneef, H.G. Slager, Christine L. Mummery, E.J.J. van Zoelen	12
7	Expression of transforming growth factor β2 during the differentiation of murine embryonal carcinoma and embryonic stem cells 1990 ·Developmental Biology ·Christine L. Mummery, H.G. Slager, W. Kruijer, A. Feijen, Eric Freund, I. Koornneef, A.J.M. van den Eijnden-van Raaij	63
8	Production of Insulin-Like Growth Factors, Platelet- Derived Growth Factor, and Transforming Growth Factors and Their Role in the Density-Dependent Growth Regulation of a Differentiated Embryonal Carcinoma Cell Line 1989 ·Endocrinology ·E.J.J. van Zoelen, I. Koornneef, Joost C. M. Holthuis, (unknown), A. Feijen, (unknown), Christine L. Mummery, S. C. van Buul-Offers	26
9	Purification of a growth factor related to platelet-derived growth factor and a type β transforming growth factor secreted by mouse neuroblastoma cells. A general strategy for the purification of basic polypeptide growth factors 1989 ·Biochemical Journal ·A.J.M. van den Eijnden-van Raaij, I. Koornneef, (unknown), (unknown), W. Kruijer, Siegfried W. de Laat, E.J.J. van Zoelen	17
10	A new method for high yield purification of type beta transforming growth factor from human platelets 1988 ·Biochemical and Biophysical Research Communications ·A.J.M. van den Eijnden-van Raaij, I. Koornneef, E.J.J. van Zoelen	40
11	Cation-exchange high-performance liquid chromatography: Separation of highly basic proteins using volatile acidic solvents 1987 ·Analytical Biochemistry ·A.J.M. van den Eijnden-van Raaij, I. Koornneef, (unknown), Siegfried W. de Laat, E.J.J. van Zoelen	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact